Results 221 to 230 of about 17,262,511 (380)

Polymorphisms in ABCB1 and CYP19A1 genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients [PDF]

, 2016
Guillermo Gervasini, Carlos Jara, C Olier, Nuria Romero-Laorden, Ruth Martínez, Juan Antonio Carrillo   +5 more
openalex   +1 more source

Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions A statement from the ESA-ESICM joint taskforce on perioperative outcome measures

European Journal of Anaesthesiology, 2015
Ib Jammer, Nadine Wickboldt, M. Sander, Andrew F Smith, M. Schultz, P. Pelosi, B. Leva, A. Rhodes, A. Hoeft, B. Walder, M. Chew, R. Pearse   +11 more
semanticscholar   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

P-1172. Characterization of Clinical Pathogens and Microbiological Outcomes for Patients Treated with IV Fosfomycin (IV-FOS) in the ZEUS Phase 2/3 Complicated Urinary Tract Infection, including Acute Pyelonephritis (cUTI/AP) Trial [PDF]

Hainv Gao, Mauricio Rodriguez, Surya Chitra, Judith N Steenbergen   +3 more
openalex   +1 more source

Correlations between age, Charlson score and outcome in clinical unilateral T3a prostate cancer [PDF]

, 2008
Chao‐Yu Hsu, Steven Joniau, Raymond Oyen, Tania Roskams, Hendrik Van Poppel   +4 more
openalex   +1 more source

Clinical Spectrum of Tuberculosis Otitis Media (TBOM) and Management Outcomes

, 2023
Generoso T. Abes, Franco Louie Abes, Teresa Luisa G. Cruz, Erasmo Gonzalo D.V. Llanes   +3 more
openalex   +2 more sources

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Clinical outcome and cost of intravenous, OPAT, and oral treatment of Gram-negative bacteremia. [PDF]

Qatar Med J
Chaponda M, Maher F, Daghfal J, Shaukat A, Al-Wali W, Hashim Al-Obaidi MK, Al Maslamani M.   +6 more
europepmc   +1 more source

STAGE-BASED THERAPEUTIC APPROACHES TO BLADDER LEUKOPLAKIA: CLINICAL OUTCOMES

Sadikova, D.I.
openalex   +1 more source

Clinical and patient‐reported outcomes of Chinese patients undergoing haemodialysis in hospital or in the community: A 1‐year longitudinal study [PDF]

, 2015
Julie Chen, Eric Yuk Fai Wan, Edmond Pui Hang Choi, Carlos King Ho Wong, Anca KC Chan, Karina H. Y. Chan, Philip KT Li, Cindy Lo Kuen Lam   +7 more
openalex   +1 more source